We demonstrate that LAPTM5 facilitates autophagosome‐lysosome fusion, thereby promoting drug resistance in malignant cells, underscoring the potential role of LAPTM5 in overcoming drug resistance in MM (Figure 7E). This evidence concerns the gene LAPTM5 and Miyoshi myopathy.